Wolsk E, Jurgens M, Schou M, Ersboll M, et al. A Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients with Type 2 Diabetes at High Cardiovascular Risk (the SIMPLE Trial). Diabetes 2022 Jan 21. pii: 140950. doi: 10.2337/db21-0721.
PMID: 35061894